Back to Results
First PageMeta Content



Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmace
Add to Reading List

Document Date: 2016-07-05 04:16:59


Open Document

File Size: 313,15 KB

Share Result on Facebook
UPDATE